BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4721370)

  • 1. Relief of chronic peripheral artery obstruction by intravenous Brinase.
    Frisch EP; Fitzgerald DE
    J Ir Med Assoc; 1973 Jun; 66(12):313-8. PubMed ID: 4721370
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombolytic treatment of arterial occlusions with brinase, a proteolytic enzyme produced by aspergillus].
    Numan D; Da Silva MA; Wikner LK; Duckert F
    Schweiz Med Wochenschr; 1974 Dec; 104(50):1865-7. PubMed ID: 4445859
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous wave ultrasound evaluation of brinase treatment of chronic arterial obstruction.
    Fitzgerald DE; Frisch EP
    Angiology; 1974; 25(7):444-8. PubMed ID: 4843179
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined thrombolytic and Dotter treatment in arterial occlusive disease.
    Eie H; Ro J; Amundsen E; Osvik K
    J Oslo City Hosp; 1972; 22(9):141-8. PubMed ID: 5075930
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical review on brinase, a protease from Aspergillus oryzae.
    Frisch EP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):63-82. PubMed ID: 4134258
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolytic treatment with i.v. brinase of advanced arterial obliterative disease of the limbs.
    Lund F; Ekeström S; Frisch EP; Magaard F
    Angiology; 1975; 26(7):534-56. PubMed ID: 1053595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approach to thrombolytic therapy: the use of Defibrase in connection with streptokinase.
    Latallo ZS; Lopaciuk S
    Thromb Diath Haemorrh Suppl; 1973; 56():253-64. PubMed ID: 4617332
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombolytic properties and side effects of brinase (fibrinolytic enzyme from Aspergillus oryzae) in the dog.
    Roschlau WH
    J Clin Pathol; 1972 Jul; 25(7):635-6. PubMed ID: 5070267
    [No Abstract]   [Full Text] [Related]  

  • 9. Relief of chronic arterial obstruction using intravenous brinase. A control study.
    FitzGerald DE; Frisch EP; Milliken JC
    Scand J Thorac Cardiovasc Surg; 1979; 13(3):327-32. PubMed ID: 396673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
    Angelkort B
    Med Welt; 1979 Aug; 30(34):1239-43. PubMed ID: 491921
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolytic agents.
    Sherry S
    Dis Mon; 1969 May; ():3-32. PubMed ID: 4241828
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with brinase.
    Frisch EP
    J Clin Pathol; 1972 Jul; 25(7):654-5. PubMed ID: 5070274
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the effectiveness of a new fibrinolytic enzyme for local thrombolysis in the Scribner shunt].
    Kessel M; Bennhold I; Froese P
    Klin Wochenschr; 1968 Dec; 46(23):1263-6. PubMed ID: 5714779
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic fibrinolysis and arterial occlusive disease].
    Lasch HG; Schöndorf TH
    Verh Dtsch Ges Inn Med; 1981; 87():314-23. PubMed ID: 7331461
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis].
    Ernst E
    MMW Munch Med Wochenschr; 1983 Sep; 125(37):796-8. PubMed ID: 6415441
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
    Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolysis by protease of Aspergillus ochraceus.
    Nowak G
    Acta Univ Carol Med Monogr; 1972; 52():113-9. PubMed ID: 4669810
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood coagulation and fibrinolytic system in patients with chronic occlusive peripheral artery disease treated with streptokinase].
    Zola-Sleczek E
    Kardiol Pol; 1973; 16(4):317-22. PubMed ID: 4756966
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of defibrotide after oral and parenteral administration in patients with peripheral obliterative arterial disease (POAD).
    Craveri A; Tornaghi G; Ranieri R; Stanzani M; Landi G; Paganardi L; Passaretti B; Gallo E
    Int Angiol; 1990; 9(4):274-7. PubMed ID: 2099963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis in arterial occlusion.
    Verhaeghe R
    Thromb Haemost; 1999 Sep; 82 Suppl 1():109-11. PubMed ID: 10695498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.